[1]
2012. Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Brazilian Journal of Pharmaceutical Sciences. 48, 3 (set. 2012), 435–446. DOI:https://doi.org/10.1590/S1984-82502012000300010.